Bruker (BRKR) to Acquire the NanoString Business

Go back to Bruker (BRKR) to Acquire the NanoString Business

Bruker to Acquire the NanoString Business in an Asset Deal

April 22, 2024 7:00 AM EDT

NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with... More